Skin Tumours

Benign Skin Tumours

Seborrhoeic Keratosis

•    "Stuck-on," waxy or verrucous appearance

•    Varying colour (brown to black)

•    Common in elderly ("barnacles of aging")

•    Sign of Leser–Trélat: sudden onset of multiple lesions may indicate internal malignancy (esp. GI)


Dermatofibroma

•    Firm, hyperpigmented nodules, often on lower limbs

•    Dimple sign: central depression on pinching

•    Usually asymptomatic; no malignant potential


Lipoma

•    Soft, mobile, painless subcutaneous mass

•    Common on trunk, shoulders

•    Composed of mature adipocytes


Pre-Malignant Lesions

Actinic (Solar) Keratosis

•    Rough, scaly erythematous plaques

•    Sun-exposed areas (scalp, face, forearms)

•    Risk of progression to squamous cell carcinoma (~1%)

Bowen’s Disease (SCC in situ)

•    Well-defined, erythematous scaly plaque

•    Full-thickness epidermal dysplasia, no dermal invasion

•    Common on sun-exposed skin, can progress to invasive SCC


Malignant Skin Tumours

Basal Cell Carcinoma (BCC)

•    Most common skin cancer, locally invasive, rarely metastasises

•    "Pearly" or translucent nodule with rolled edge, central ulceration ("rodent ulcer"), telangiectasia

•    Risk factors: UV exposure, fair skin, immunosuppression (e.g., post-transplant)

•    Subtypes: nodular (most common), superficial, morphoeic

Treatment

•    Surgical excision with margin

•    Mohs micrographic surgery (facial lesions)

•    Topical treatments (imiquimod, 5-FU) for superficial BCC


Squamous Cell Carcinoma (SCC)

•    Hyperkeratotic, crusted, or ulcerated nodule

•    Arises from actinic keratosis or chronic wounds (Marjolin’s ulcer)

•    Higher metastatic potential than BCC (but still low overall)

Risk factors

•    UV exposure, chronic inflammation (e.g., ulcers, scars)

•    Immunosuppression (e.g., transplant patients up to 100× risk)

•    HPV infection (anogenital SCC)

Treatment

•    Surgical excision with margin

•    Radiotherapy (alternative in inoperable cases)


Malignant Melanoma

•    Arises from melanocytes

•    ABCDE criteria:

o    A: Asymmetry

o    B: Border irregular

o    C: Colour variation

o    D: Diameter >6 mm

o    E: Evolution (changing)

Types

•    Superficial spreading: most common, horizontal growth phase

•    Nodular: rapid vertical growth, poorer prognosis

•    Lentigo maligna: slow-growing, sun-exposed elderly skin

•    Acral lentiginous: palms, soles, subungual; more common in darker skin types

Prognostic factors

•    Breslow thickness (most important for prognosis)

•    Ulceration, mitotic rate, lymphovascular invasion

Treatment

•    Wide local excision

•    Sentinel lymph node biopsy for staging


Other Malignant Skin Tumours

Merkel Cell Carcinoma

•    Rare, aggressive neuroendocrine tumour

•    Red–violaceous rapidly growing nodule, sun-exposed areas

•    Often in elderly or immunosuppressed

•    High rate of local recurrence and metastasis


Cutaneous Lymphomas

•    Most common: Mycosis fungoides (cutaneous T-cell lymphoma)

•    Presents as scaly patches plaques tumours

•    Sézary syndrome: erythroderma, circulating malignant T cells (Sézary cells)


Extra Revision Pearls

•    Chronic ulcer or burn scar SCC (Marjolin’s ulcer)

•    Multiple rapidly growing keratoacanthomas think Muir–Torre syndrome (subset of Lynch)

•    Melanoma staging relies heavily on Breslow depth

•    Immunosuppressed patients SCC risk dramatically increased


————————————————————————————————————————————————————————————————————————————————————————————————————————-

Author & Educational Disclaimer


Author:

Dr Phillip Cockrell BM FRCP DipClinEd


Dr Phillip Cockrell is a UK Consultant Physician in Internal Medicine, currently working at Queen Alexandra Hospital, Portsmouth University Hospitals NHS Trust. He has previously worked as a registrar across Intensive Care Medicine, Gastroenterology, Cardiology, Stroke Medicine, Acute Medicine, and Respiratory Medicine.


He has held senior leadership roles including Associate Clinical Director of the Acute Medical Unit, Clinical Director of Internal Medicine, and Chief of Medicine. Dr Cockrell has over 15 years’ experience in postgraduate medical education, having lectured extensively across the MRCP syllabus and contributed to MRCP revision teaching and course development.


Dr Cockrell holds a Bachelor of Medicine (BM), Fellowship of the Royal College of Physicians (FRCP), and a Diploma in Clinical Education (DipClinEd). His teaching approach is based on structured consolidation of complex medical topics to support efficient and effective revision for postgraduate examinations.


Purpose of this content:

The material on this page is intended solely for educational purposes to support revision for the MRCP (UK) Part 1 examination. It reflects examination-relevant principles of internal medicine and is designed to aid learning and pattern recognition.


Medical disclaimer:

This content is designed for postgraduate medical examination revision and does not constitute medical advice, diagnosis, or treatment guidance and must not be used as a substitute for professional clinical judgement, local guidelines, or specialist consultation. Clinical decisions should always be made in the context of individual patient circumstances and current national guidance.